Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020.
Euro Surveill
; 25(28)2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: covidwho-647502
ABSTRACT
Serological reactivity was analysed in plasma from 436 individuals with a history of disease compatible with COVID-19, including 256 who had been laboratory-confirmed with SARS-CoV-2 infection. Over 99% of laboratory-confirmed cases developed a measurable antibody response (254/256) and 88% harboured neutralising antibodies (226/256). Antibody levels declined over 3 months following diagnosis, emphasising the importance of the timing of convalescent plasma collections. Binding antibody measurements can inform selection of convalescent plasma donors with high neutralising antibody levels.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Neumonía Viral
/
Infecciones por Coronavirus
/
Anticuerpos Neutralizantes
/
Betacoronavirus
Tipo de estudio:
Estudios diagnósticos
/
Estudio pronóstico
Límite:
Adolescente
/
Adulto
/
Anciano
/
Humanos
/
Middle aged
/
Young_adult
País/Región como asunto:
Europa
Idioma:
Inglés
Asunto de la revista:
Enfermedades Transmisibles
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
1560-7917.ES.2020.25.28.2001260
Similares
MEDLINE
...
LILACS
LIS